Site Search

This week on Facing the Future our guest was Austin Smythe who has over 30 years of experience working in both the legislative and executive branches of the Federal government.

WASHINGTON -- While the nation’s attention is justifiably focused on multiple other crises, today’s publication of the Social Security and Medicare trustees reports reminds us of another call to action: averting the financial crisi

Introduction The impact of the Social Security program on the Federal budget has been the subject of much controversy and confusion.  Indeed, disagreement between the Social Security and Medicare actuaries resulted in a lengthy addition to the “Statement of Actuarial

Budget Breakthrough

This week on Facing the Future, we took a break from the federal budget but kept our focus on public sector budgeting. States have budgets too and the choices can be just as difficult and just as impactful on constituents as the federal budget.

Part 2: College Students Introduction President Biden’s FY 2022 Budget proposes to spend nearly $1.7 trillion over the next ten years on several new or expanded entitlement programs for children, college students, the elderly, and the disabled.  T

This week on Facing the Future we heard from Tom Kahn, a veteran Democrat congressional staffer who is concerned that both parties have abandoned fiscal discipline. Concord’s National Field Director Phil Smith joined the conversation. 

Democrats announced in early July that the progressive and moderate wings of the party had agreed to a top line spending level of $3.5 trillion for the upcoming reconciliation bill. They also promised to pay for most, if not all, of this package.

It’s understandable, even laudable, that political leaders want to do big things that improve the lives of their constituents. And it’s good that they acknowledge the need to pay for what they want to do.

This week on Facing the Future, we turned to health care and the brewing controversy over Aduhelm, a new drug for treating Alzheimer's Disease that was recently approved by the Food and Drug Administration (FDA).